Sat, June 14, 2025
Fri, June 13, 2025
Thu, June 12, 2025

Novo Nordisk overtakes SAP as Europe's most valuable company

  Copy link into your clipboard //business-finance.news-articles.net/content/202 .. takes-sap-as-europe-s-most-valuable-company.html
  Print publication without navigation Published in Business and Finance on by Fortune
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Novo's market capitalization reached $365 billion, slightly surpassing SAP's valuation of $364.3 billion.
Novo Nordisk has surpassed SAP to become Europe's most valuable company, with a market capitalization of $600 billion compared to SAP's $220 billion. This shift is attributed to the soaring demand for Novo Nordisk's weight-loss and diabetes drugs, Wegovy and Ozempic, which have seen significant success in the U.S. market. The company's stock has risen by 50% over the past year, reflecting strong investor confidence in its growth potential. Meanwhile, SAP, a leader in enterprise software, has experienced slower growth, contributing to its decline in market value relative to Novo Nordisk.

Read the Full Fortune Article at:
[ https://fortune.com/europe/2025/06/13/novo-nordisk-overtakes-sap-europe-most-valuable-company/ ]